Abstract
Introduction
Cancer cells selected for resistance against natural product drugs, such as doxorubicin, are often crossresistant to a range of structurally and functionally unrelated drugs. This type of drug resistance is called Ž . multidrug resistance MDR . The classical form of MDR is caused by the enhanced expression of the Ž . MDR1 gene, which encodes the P-glycoprotein Pgp . Pgp is an ATP-dependent drug export pump located w x in the plasma membrane of various cell types 1 . Recently, a second ATP-dependent transporter of anti-tumor drugs has been identified in mammalian Ž . w x cells, the multidrug resistance protein MRP 2 . Transfection studies showed that MRP could confer resistance to a wide spectrum of natural product w x drugs 3,4 . MRP overexpressing cells are resistant to anthracyclines, to vinca alkaloids and especially to w x etoposide 4-8 . Expression of MRP did not confer w x resistance to cisplatin 5, 6 .
Isolated plasma membrane vesicles of MRP-transfected cells exhibited an ATP-dependent transport of Ž . glutathione GS -conjugates, such as leukotriene-C 4 Ž . and dinitrophenyl-glutathione GS-DNP . Vesicles from untransfected cells exhibited only little such w x transport 9,10 . In addition, isolated plasma membrane vesicles from drug-resistant cell lines that over-Ž . express MRP GLC4rADR and HL60rADR possessed an ATP-dependent transport system for GSconjugates. This transport activity was almost absent in the parental human small-cell lung cancer cell line, w x GLC4, and the leukemic cell line HL60 10,11 .
The studies with isolated plasma membranes suggested that MRP functions as a transporter of negatively charged GS-conjugates. In experiments with intact cells, expression of MRP also conferred resistance to neutral and positively charged amphiphilic drugs. It has been suggested that these drugs are metabolized to anionic compounds that are transported by MRP. Reduction of the cellular glutathione Ž . GSH content by inhibiting its synthesis with buthionine sulfoxime, decreased drug resistance to daunoru-Ž . w bicin DNR in MRP overexpressing cell lines 12-x 15 . This suggested that the conjugation with glutathione might be the relevant metabolism or that Ž . glutathione is involved in a transient complex formation. No such effect was seen in Pgp overexpressw x ing cell lines 13-15 . Pgp transports unconjugated w x DNR 16 . However, such metabolites of, for instance, DNR have not been found in MRP drug-resistant cell lines and it has not yet been excluded that w x DNR itself is transported by MRP 17 .
In order to gain more insight into the substrate specificity of MRP, we isolated plasma membrane vesicles of GLC4rADR cells and studied the ATPdependent uptake of GS-DNP into these vesicles. This transport could be inhibited by several anionic and cationic drugs. 
Materials and methods

Chemicals
w 3 x Ž . H GSH
Cells
The GLC4 and GLC4rADR human small cell w x lung cancer cell lines 22 were grown in RPMI medium supplemented with 7% heat-inactivated FCS at 378C in a humidified atmosphere of 5-6% CO . 2 The GLC4rADR cell line was cultured in the presence of 1 mM of DOX until one week before plasma membrane isolation.
Plasma membrane Õesicles
Plasma membrane vesicles derived from GLC4 and GLC4rADR cells were isolated following a w x method adapted from Garrigos et al. 23 . Cells were Ž . harvested by centrifugation 275 = g, 5 min and washed once in phosphate-buffered saline. After incubating the cells in 100 mM KCl, 5 mM MgCl , 1 2 Ž . mM PMSF and 50 mM HepesrKOH pH 7.4 for 1 h on ice, the cells were ultrasonicated at 20% of the maximum power of an M.S.E. Soniprep 150 sonica-Ž . tor for 3 bursts of 15 s. The homogenate 2.5 mgrml Ž . was centrifuged 1500 = g, 10 min . The post-nuclear supernatant was layered on top of a 46% sucrose Ž . cushion. After centrifugation 100 000 = g, 60 min the interface was removed and washed in 100 mM Ž .Ž KCl and 50 mM HepesrKOH pH 7.4 100 000 = g, . 20 min The final pellet was resuspended in 100 mM Ž . KCl and 50 mM HepesrKOH pH 7.4 by drawing the suspension 5 times through a 27-G needle. The final membrane preparations were stored at y808C at a protein concentration of ; 4 mgrml.
Marker enzyme activities were measured to deterŽ mine enrichment of Na -K -ATPase plasma mem-. w x Ž . w x brane 24 , of esterase endoplasmic reticulum 25 , Ž .w x of acid phosphatase lysosomes 26 and of gluta-Ž .w x mate dehydrogenase mitochondria 27 . Protein was Ž . determined by the Bio-Rad Munchen, Germany protein assay.
Uptake studies
Uptake was measured by rapid filtration as previw x Ž ously described 28 . Plasma membrane vesicles ;
. 0.25 mg proteinrml were incubated for the indicated time at 378C in 100 mM KCl, 50 mM HepesrKOH Ž . pH 7.4 , 10 mM MgCl with or without 2 mM ATP 2 w 3 x Ž and with either H GS-DNP 1.6 kBqrpmol, 32
. w 3 x Ž . Bqrml or H GSSG 3.2 kBqrpmol, 32 Bqrml or w 3 x Ž . H methotrexate 636 Bqrpmol, 190 Bqrml . Incubation was stopped by adding 2.5 ml of ice-cold 100 Ž . mM KCl, 50 mM HepesrKOH pH 7.4 to 50 ml of the uptake medium. When the incubation time exceeded 5 min 50 ml was removed from a larger volume, incubated in a closed vial to prevent evapo-Ž ration. After rapid filtration, filters OE67, Schleicher . and Schuell, Dassel, Germany were washed twice Ž . with the stop buffer 2.5 ml . Both substrate and inhibitors were mixed with the vesicles at the start of the incubation. Polyclonal antibodies were preincubated on ice with the plasma membrane vesicles for at least 1 h, giving a 25 times dilution of the antiserum in the final incubation medium. The ATP-dependent uptake was determined by the difference between the uptake in the presence and that in the absence of ATP.
Calculations
The rate equation for the pocket model was derived from the following scheme.
In this scheme the binding site is represented by E. 
In Section 3, data are presented as mean " S.E.M. Ž . Signifance of differences P -0.05 between values were calculated with the Student t-test and between variations of the fits with an F-test.
Results
The final plasma membrane fraction had an enrichment of Na q -K q -ATPase by 5 times, of esterase by 1.4 times, of acid phosphatase by 2.5 times and of glutamate dehydrogenase by 0.3 times as compared to whole cells. In the assay, additional effective enrichment was obtained by only considering the ATP-dependent part of the uptake rate.
GS-DNP uptake
Uptake of GS-DNP into membrane vesicles of GLC4rADR was stimulated by the addition of ATP Table 1 Kinetic constants of the ATP-dependent GSDNP and GSSG uptake into GLC4rADR membrane vesicles GS-DNP uptake GSSG uptake
The kinetic parameters were derived from n separate experiments as depicted in Fig. 2 . The uptake of GS-DNP was measured in 15 s and of GSSG in 6 min. Data are presented as mean" S.E.M. membrane vesicles of GLC4rADR cells was linear with time for at least 15 s. This uptake was saturable for GS-DNP and ATP as shown in Fig. 2 . The relation between the uptake rate of GS-DNP and the ATP or GS-DNP concentration fitted MichaelisMenten kinetics. The kinetic constants which were obtained are summarized in Table 1 .
The ATP-dependent uptake of 10 nM of GS-DNP was studied in the presence and absence of several polyclonal antibodies raised against MRP as shown by Fig. 3 . Only the polyclonal antiserum raised against FP-V inhibited the ATP-dependent GS-DNP uptake to 11 " 5% compared to a control serum. This may very well indicate that this segment of MRP is important for MRP function.
The influence of several organic compounds on the ATP-dependent uptake of 10 nM GS-DNP is shown in Table 2 . Organic anions, such as bile acids, probenecid, GSSG, MTX and calcein inhibited the GS-DNP transport. Taurine-conjugated bile acids were potent inhibitors. 3-Sulfated bile acids and more Ž . hydrophobic bile acids, such as 3-sulfated taurolitocholic acid, were the most potent inhibitors. The cholephilic organic anion ICG also inhibited GS-DNP transport. In addition to these organic anions, anthracyclines, vinca alkaloids, VP16, taxol, as well as w 3 x Uptake in 15 s of 10 nM H GS-DNP into membrane vesicles of GLC4rADR was measured in the presence and absence of 2 mM ATP. The ATP-dependent uptake of GS-DNP in the presence of the indicated organic compound was related to the ATP-dependent uptake of GS-DNP in its absence in three separate experiments. Control uptake was 0.76 " 0.11 pmol GS-DNPrmgrproteinr15 s. The abbreviations are: ICG, indocyanine green; TC, taurocholate; STC, 3-sulfated TC; TLC, taurolithocholate; STLC, 3-sulfated TLC. Data Ž . are presented as mean " S.E.M. n G 3 .
calcein-AM inhibited the ATP-dependent transport of GS-DNP. At the concentrations in which they were used verapamil and rhodamine-123 did not inhibit GS-DNP uptake.
w 3 x Uptake of the organic anions H MTX and w 3 x H GSSG into membrane vesicles prepared from Ž GLC4rADR cells was also stimulated by ATP Table 1 .
Inhibition mechanisms
We further studied the nature of the interference of DNR with GS-DNP uptake representative of the w x non-anionic cytostatic drugs 33 . Fig. 5A suggests Ž that the inhibition by DNR is non-competitive the slope reflecting the K for GS-DNP is not affected m . by DNR . DNR forms complexes with a variety of w x organic compounds 34 . The formation of a complex between GS-DNP and DNR which consequently decreases the free GS-DNP concentration could explain the lowering of GS-DNP transport activity by DNR.
To exclude this possibility we tested whether GS-DNP could compete with DNA for the binding to DNR. If binding of DNR to GS-DNP is the cause of inhibition, the K of such a complex must be in the same To further test this conclusion we studied the dose-dependent inhibition of GS-DNP transport by DNR in Ž . the presence of DNA 1 mgrml . DNA buffers the free DNR concentration. The free DNR concentration in the presence of 1 mgrml DNA at the same conditions of the uptake studies was determined as 5% of the total DNR concentration. To obtain the same inhibitory effect of DNR in the presence of 1 mgrml DNA, we had to apply a 20 times higher DNR concentration.
We also studied inhibition of GSSG transport by DNR as shown in Fig. 5B . This figure shows that the inhibition by DNR of the GSSG transport, in contrast to that of GS-DNP, was competitive.
The inhibition by DNR of the GS-DNP transport fitted significantly better to a non-competitive type of interaction, whereas that of GSSG to a competitive type of interaction. In order to explain these different effects we propose a binding pocket that binds in random order DNR and GS-DNP or GSSG. When this model was applied to the data of the studies with Ž GS-DNP transport the best fit with a weighting GSSG and DNR shows strongly negatively co-oper-Ž . ative competitive binding. Because of this low a , f could not be predicted accurately. The K of DNR i found for GS-DNP transport was not significantly different from that found for GSSG transport. The a and f for GS-DNP and DNR predict that high concentrations of DNR cannot inhibit GS-DNP com-( ) Fig. 6 . Inhibition by high daunorubicin concentrations of the ATP-dependent GS-DNP and GSSG uptake into membrane vesiw 3 x cles from GLC4rADR cells. The uptake of 10 nM H GS-DNP Ž .
w 3 x Ž . B and H GSSG v was measured at different concentrations of daunorubicin. Uptake without DNR was set at 100%.
pletely. To validate this model we tested this as shown in Fig. 6 . Transport of GSSG was almost completely inhibited by 500 mM DNR, whereas GS-DNP transport could not be further inhibited till ; 40 " 20% of the control uptake.
A different explanation may be the presence of two ATP-dependent transporters for GS-DNP, one sensitive to DNR and the other insensitive to DNR. The calculated K of DNR for this proposed DNRi sensitive GS-DNP transporter was 0.43 " 0.13 mM, which is lower than for the GSSG-transporter.
Discussion
This study shows that the GS-conjugate GS-DNP is transported in an ATP-dependent manner into membrane vesicles of MRP overexpressing GLC4rADR cells. This transport was almost absent from membrane vesicles derived from the drug-sensitive parental cell line, GLC4. Fig. 1 shows that at 10 nM GS-DNP more than 8 pmol of GS-DNP per mg protein could be taken up in the presence of ATP. Even if we overestimate the vesicular volume of the Ž . plasma membrane vesicles 10 mlrmg prot. and assume that all these vesicles are inside-out plasma membranes, there would exist a concentration ratio for GS-DNP across the membrane which is more than 80. A significant part of this ratio may correspond to a ratio of free concentrations rather than due to intravesicular binding, as no such uptake was observed after long incubation in the absence of ATP.
These results confirm the findings of Muller et al. w x 10 . Here, the inhibition by the polyclonal antiserum raised against a fusion protein containing a segment of MRP provides additional evidence that the ATPdependent transport of GS-DNP and other GS-conjugates is mediated by MRP in GLC4rADR cells. Muller . Oxidized glutathione GSSG inhibited ATP-dependent GS-DNP transport. GSSG also inhibited leukotriene-C transport, although to a lower extent; 4 w x 0.5 mM of GSSG reduced the uptake to 48% 10 . We found that the uptake of GSSG could be stimulated by ATP in membrane vesicles from GLC4rADR and not in those from the parent GLC4 Ž cells. The calculated V of GSSG transport 0.9 max . nmolrmgrmin is in the same range as that of Ž . GS-DNP 0.56 nmolrmgrmin . This suggests that GSSG, too, is transported by the system that transports GS-DNP, i.e., by MRP.
Other organic anions that are not GS-conjugates could also inhibit the GS-DNP uptake. The substrate specificity of MRP expressed in GLC4rADR memw x brane vesicles resembles that of MOAT 28,41 , with respect to organic anions. The uptake of the inhibitory organic anion and anticancer drug MTX, into GLC4rADR membrane vesicles was stimulated by ATP. Such a stimulation was not observed for membrane vesicles of GLC4 cells; MTX also appears to be a substrate of MRP. The ATP-dependent transport system for MTX described in isolated inside-out plasma membrane vesicles of L1210 leukemia cells w x 42 may well be MRP proper.
( )The fluorescent organic anion calcein has been w x used as a probe of MRP activity in intact cells 15 . In the cellular studies the acetoxymethyl ester of calcein, calcein-AM, was given to cells. This lipophilic neutral compound diffuses into the cell where it is hydrolysed to fluorescent calcein. MRP expressing cells extrude the latter compound. The interpretation of the studies in intact cells was that mainly, but not exclusively, the free calcein is exw x truded by MRP 15 . In this study calcein-AM inhibited transport 30 times more strongly than calcein itself. As inhibition and transport may be only partly related, this does not exclude that the actual export rate of calcein-AM by MRP in intact cells is much slower than that of calcein.
In addition to calcein-AM many natural product drugs inhibited GS-DNP transport, although they were not anionic. The inhibition by vincristine and vinblasw x tine confirms the results of Muller et al. 10 . In thë quoted publication, these authors could not detect an inhibition by doxorubicin in their experimental conditions. However, when they applied our membrane preparation and experimental conditions, both DNR Ž . Ž . 10 mM and doxorubicin 10 mM reduced the Ž . uptake of leukotriene C 2.3 nM to 47% and 33%, w x This is in line with the recent work of Loe et al. 43 .
DNR appeared to compete with the binding of GSSG and inhibited GS-DNP transport in a non-competitive way. The different kinetic behavior of DNR towards GSSG and GS-DNP transport may suggest that GSSG and GS-DNP bind to different sites on MRP. However, it is more likely that both glutathione-conjugates bind to the same site. An alternative explanation is the presence of two ATP-dependent transporters for GS-DNP, one sensitive to DNR and the other insensitive to DNR. This is not very Ž . likely because 1 both transporters must have the Ž . same K for GS-DNP, 2 both transporters must be m equally induced in GLC4rADR cells and have a low Ž . expression in GLC4 cells. 3 The first transporter must transport GSSG with a K of 43 mM while the m second must be a low affinity system for GSSG, Ž . whereas for GS-DNP it is a high affinity system. 4 Many compounds inhibit dose-dependently GS-DNP Ž transport and can block transport completely data . Ž . not shown and 5 the calculated K of DNR for the i supposed DNR sensitive GS-DNP transporter is half the K for the GSSG-transporter. However, as explai nation we propose a model including a binding pocket on MRP in which both DNR and the GS-conjugate Ž . bind Fig. 7 . In this model, the pocket is large enough to bind both GS-DNP and DNR. But if GSSG is present in the pocket, the binding of DNR is prevented, possibly by steric hindrance. Accordingly, when GS-conjugate and DNR are present in the pocket, GS-conjugate can still be transported. This may explain the contradictory finding that DNR not always gives an inhibition of GS-DNP transport. When the factor f and a equal one DNR will not give an inhibition of GS-DNP transport.
At the conditions described, uptake of DNR into membrane vesicles of GLC4rADR cells could not be stimulated by ATP. This lack of ATP-stimulation could be caused by a high passive efflux rate of DNR compared with the active uptake rate, resulting in an insignificant accumulation. Recently, ATP-dependent transport of DNR in membrane vesicles from MRP w x overexpressing cells has been shown 44 . The analysis of the type of inhibition of GS-DNP and GSSG transport by DNR suggests that DNR binds to the same site as, or in the neighborhood of GSSG and GS-DNP. This makes it plausible that DNR is indeed Ž . co-transported by MRP. This model is in agreement w x with the results of Loe et al. 43 . They showed that ATP-dependent accumulation of vincristine in membrane vesicles of MRP expressing cells was stimulated by glutathione. In this study we showed that MRP transports organic anions, such as GS-DNP, GSSG and MTX. This transport is specifically inhibited by a polyclonal antibody raised against a fusion protein containing a segment of MRP. At present we are characterizing a monoclonal antibody that also inhibits ATP-dependent transport of GS-DNP into membrane vesicles derived from GLC4rADR cells. The kinetics of the inhibition of anthracyclines suggests the presence of a binding pocket in MRP. This model of a binding pocket may be of importance for understanding the broad substrate specificity of transporters such as MRP and P-glycoprotein. However, further detailed kinetic analysis of transport by these proteins is needed.
